Cosmos Holdings Inc (COSM)
NASDAQ:COSM
Want to see COSM full AI Analyst Report?
COSM Stock Chart & Stats
$0.52
-$0.04(-5.45%)
At close: 4:00 PM EST
$0.52
-$0.04(-5.45%)
Day’s Range― - ―
52-Week Range$0.25 - $1.32
Previous CloseN/A
Volume59.12K
Average Volume (3M)1.18M
Market Cap
$15.55M
Enterprise Value$32.08M
Total Cash (Recent Filing)$548.93K
Total Debt (Recent Filing)$18.48M
Price to Earnings (P/E)―
Beta1.98
Next Earnings
Aug 24, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding59,956,993
10 Day Avg. Volume1,246,475
30 Day Avg. Volume1,183,471
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.23
P/FCF Ratio-1.77
Enterprise Value/Market Cap2.06
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit4.44
Enterprise Value/Ebitda-1.90
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.08
Revenue Forecast (FY)$103.20M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthTTM revenue of roughly $69.5M demonstrates durable top-line momentum across the core distribution and related businesses. Consistent revenue growth provides a foundation to scale margins and amortize fixed costs over time, supporting longer-term operational leverage if costs are controlled.
Improved Leverage And Positive EquityLeverage improvement to a ~0.48 debt/equity ratio and positive equity reduce near-term solvency risk versus 2025. Lower leverage increases financial flexibility for investments or working capital, lessening refinancing pressure and providing a stronger base while the company pursues profitability improvements.
Diversified B2B Distribution & ManufacturingA mix of pharmaceutical distribution, nutraceuticals and contract manufacturing spreads commercial and regulatory risk and creates multiple revenue channels. Reported global expansion and new manufacturing agreements indicate structural capability expansion that can produce more stable, recurring B2B revenues over time.
Bears Say
Persistent Operating Losses And Thin MarginsThin gross margins and sustained deep operating losses show structural profitability weakness. Low margins constrain the company's ability to fund SG&A, R&D, and growth initiatives internally; without material margin expansion, revenue growth alone may not translate into sustainable earnings.
Negative Operating And Free Cash FlowPersistent negative OCF and FCF mean the business is consuming cash rather than self-funding operations or growth. Continued cash burn elevates reliance on external financing, increasing dilution or interest costs and limiting the company's ability to invest strategically over the medium term.
Negative Returns On EquityA negative ROE indicates current capital deployment is eroding shareholder value. If returns remain negative, the company will struggle to attract accretive equity investment and justify reinvestment, making recovery dependent on operational fixes that restore profitability and cash generation.
Cosmos Holdings News
COSM FAQ
What was Cosmos Holdings Inc’s price range in the past 12 months?
Cosmos Holdings Inc lowest stock price was $0.25 and its highest was $1.32 in the past 12 months.
What is Cosmos Holdings Inc’s market cap?
Cosmos Holdings Inc’s market cap is $15.55M.
When is Cosmos Holdings Inc’s upcoming earnings report date?
Cosmos Holdings Inc’s upcoming earnings report date is Aug 24, 2026 which is in 85 days.
How were Cosmos Holdings Inc’s earnings last quarter?
Currently, no data Available
Is Cosmos Holdings Inc overvalued?
According to Wall Street analysts Cosmos Holdings Inc’s price is currently Overvalued.
Does Cosmos Holdings Inc pay dividends?
Cosmos Holdings Inc does not currently pay dividends.
What is Cosmos Holdings Inc’s EPS estimate?
Cosmos Holdings Inc’s EPS estimate is 0.01.
How many shares outstanding does Cosmos Holdings Inc have?
Cosmos Holdings Inc has 59,956,993 shares outstanding.
What happened to Cosmos Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cosmos Holdings Inc?
Currently, no hedge funds are holding shares in COSM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cosmos Holdings Inc
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Technical Analysis
Ownership Overview
14.78% Insiders
0.51% Mutual Funds
<0.01% Other Institutional Investors
84.48% Public Companies and
Individual Investors